CircSEPT9通过通过海绵化miR-625-5p调节PTBP3表达来促进乳腺癌的进展
Guangtao Shi1, Hongbo Li2, Ying Chen2
1Zhejiang Society for Mathematical Medicine, Hangzhou, China.
Thoracic cancer
|February 27, 2024
概括
循环RNA Septin 9 (circSEPT9) 通过通过海绵式微RNA-625-5p (miR-625-5p) 增加聚胺通道结合蛋白3 (PTBP3) 水平,促进乳腺癌 (BC) 的进展. 沉默circSEPT9可以抑制BC细胞的增殖和迁移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌 (BC) 是一种影响妇女健康的流行恶性瘤.
- 循环RNAs (circRNAs) 在各种癌症中发挥着重要作用,包括BC.
- 了解BC进展中circRNAs的分子机制至关重要.
研究的目的:
- 研究circRNA Septin 9 (circSEPT9) 在乳腺癌进展中的作用和分子机制.
- 为了阐明circSEPT9,microRNA-625-5p (miR-625-5p) 和BC中的多胺管结合蛋白3 (PTBP3) 之间的相互作用.
主要方法:
- 定量实时PCR (qRT-PCR) 和西布洛特测试以评估分子水平.
- 细胞计数套件-8 (CCK8),EDU,流细胞计量,Transwell,以及用于功能分析的伤口愈合试验.
- 双露西法酶记者和RNA免疫沉 (RIP) 测试以确认相互作用;体内异种移植模型用于验证.
主要成果:
- 在BC组织和细胞中,circSEPT9过度表达.
- circSEPT9 knockdown 抑制了BC细胞的增殖,迁移,上皮-介质细胞过渡 (EMT) 和糖解,同时促进了细胞亡.
- circSEPT9针对miR-625-5p,miR-625-5p通过降低PTBP3.3的调节来调节BC细胞表型.
结论:
- circSEPT9通过通过海绵化miR-625-5p对PTBP3进行上调来促进BC恶性进展.
- circSEPT9作为BC发育和进展的关键调节者.
- 针对circSEPT9/miR-625-5p/PTBP3轴可能为BC提供治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K


